Viyana Drugs Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 1 Year 8 Months
About Viyana Drugs
Viyana Drugs Private Limited (VDPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 May 2023 (One year and eight months 6 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Paper Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Koukuntla Reddy, Anjaiah Venkamasetty, Bollam Reddy, and One other member serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U21001TS2023PTC173471
-
Company No.
173471
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
29 May 2023
-
Date of AGM
-
-
Date of Balance Sheet
-
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Viyana Drugs?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijay Godala
|
Managing Director | 29-May-2023 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Bollam Reddy
|
Whole-Time Director | 29-May-2023 | Current |
|
Koukuntla Reddy
|
Whole-Time Director | 29-May-2023 | Current |
|
Anjaiah Venkamasetty
|
Whole-Time Director | 29-May-2023 | Current |
Financial Performance of Viyana Drugs.
Enhance accessibility to Viyana Drugs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Viyana Drugs?
Unlock access to Viyana Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Meenaakshi Molecules Private LimitedAnjaiah Venkamasetty is a mutual person
-
Vals Pharma Private LimitedKoukuntla Reddy, Anjaiah Venkamasetty and 2 more are mutual person
-
Sri Padmavathi Breeding Farms Private Limited
Bollam Reddy and Vijay Godala are mutual person
-
Parvy Pharma Private Limited
Bollam Reddy and Vijay Godala are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Viyana Drugs?
Unlock and access historical data on people associated with Viyana Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Viyana Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Viyana Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.